Sector portfolio · VC firm · South Korea
KB Investment's Biotech portfolio
KB Investment has backed 11 Biotech startups in rounds we track, $336M between them, shown by the stage each has reached. The best-funded is Arvelle Therapeutics.
Funding by segment
- Series A$250M5
- Series B$32M2
- Stage not reported$23M2
- Series C and later$31M2
Where they are based
- South Korea9$109M
- Switzerland1$223M
- United States1$3.8M
South Korea
Switzerland
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M4
- $10M to $50M6
- $50M to $250M1
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
11 of 11 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- South Korea9
- Switzerland1
- United States1
Startups by country, 3 countries in all.
Segment by segment
Series A
5 startups · $250M raised
Arvelle TherapeuticsArvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solution.Switzerland$223M- DBDAAN BiotherapeuticsDAAN Biotherapeutics develops novel treatments for cancer patients.South Korea$17M
Dr. Noah BiotechEstablished in 2017, DR.NOAH BIOTECH Inc.South Korea$3.8M
ApollonApollon Inc.United States$3.8M
Nature GluetechNature Gluetech develops mass production technology and commercialization technology for bioadhesives.South Korea$2.2M
Series B
2 startups · $32M raised
MediMabBioMediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.South Korea$18M
LN RoboticsLN ROBOTICS is a South Korea-based medical robotics company founded in 2019.South Korea$15M
Stage not reported
2 startups · $23M raised
- BBeyondBioBeyondBio is a biotechnology firm that specializes in the research and development of synthetic pharmaceutical drugs.South Korea$14M
Pinot BioPinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.South Korea$9.5M
Series C and later
2 startups · $31M raised
- SBSpark BiopharmaSpark Biopharma is a biotechnology companySouth Korea$21M
ConnextConnext is a clinical-stage biotechnology company headquartered in South Korea that creates regenerative medicine technologies andSouth Korea$10M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names KB Investment as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like KB Investment?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.